EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation

Yue Tang, Hewen Chen, Ziyue Zhao, Xuesong Kang, Wenxin Wang, Kun Dai, Yufei Guo, Axin Liang iD, Aiqin Luo iD, Zikai Hao

iMetaOmics · 2025-12 · 2 (4)

DOI: 10.1002/imo2.70065 ↗

At a glance

Übersichtsarbeit in iMetaOmics, published online on 2025-11-24. Written by Yue Tang and 9 co-authors. Institution: Key Laboratory of Molecular Medicine and Biotherapy, the Ministry of Industry and Information Technology, School of Life Science Beijing Institute of…. Cited 9 times so far (Crossref); 161 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The theoretical framework of the microbiota‐gut‐brain axis (MGBA) elucidates the influence of gut microbiota (GM) on the central nervous system (CNS) and offers novel approaches for diagnosing and treating neurological disorders. The application of microfluidic organ chips to study this axis represents an innovative methodology, enabling multidisciplinary assessment of drug effects. Bionic microphysiological systems based on these chips establish a groundbreaking paradigm for analyzing cross‐organ interaction mechanisms within the MGBA. This technology facilitates systematic evaluation of pharmacokinetics, host‐microbe coevolution, and neuroendocrine regulation, thereby supporting multimodal cross‐validation in pharmacodynamics, toxicology, and translational medicine. This review summarizes the conceptual foundation and mechanistic insights of the MGBA, highlights recent advances in its constituent Multiorgan components, including gut‐on‐a‐chip, blood‐brain barrier‐on‐a‐chip, and brain‐on‐a‐chip models, alongside multiorgan chip cascade technologies, and underscores their applications in drug evaluation. Additionally, it discusses future challenges and developmental directions for the MGBA multiorgan chip technologies in this field.

Subjects

Author keywords

drug evaluationmicrobiota‐gut‐brain axismicrofluidicsorgan‐on‐a‐chip

Authors and institutions

  • Key Laboratory of Molecular Medicine and Biotherapy, the Ministry of Industry and Information Technology, School of Life Science Beijing Institute of Technology Beijing China.
  • Advanced Technology Research Institute Beijing Institute of Technology Jinan China.
  • Institute of Environmental Biology and Life Support Technology, School of Biological Science and Medical Engineering Beihang University Beijing China.
  • Shandong Institute for Food and Drug Control Jinan China.
  • Department of Statistics the George Washington University Washington District of Columbia USA.

ORCID profiles: Axin Liang, Aiqin Luo

Cite

APA

Tang, Y., Chen, H., Zhao, Z., Kang, X., Wang, W., Dai, K., Guo, Y., Liang, A., Luo, A., & Hao, Z. (2025). Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation. iMetaOmics, 2(4). https://doi.org/10.1002/imo2.70065

Vancouver

Tang Y, Chen H, Zhao Z, Kang X, Wang W, Dai K, et al. Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation. iMetaOmics. 2025;2(4). doi:10.1002/imo2.70065

BibTeX
@article{Tang2025,
  author = {Tang, Yue and Chen, Hewen and Zhao, Ziyue and Kang, Xuesong and Wang, Wenxin and Dai, Kun and Guo, Yufei and Liang, Axin and Luo, Aiqin and Hao, Zikai},
  title = {Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation},
  journal = {iMetaOmics},
  year = {2025},
  volume = {2},
  number = {4},
  doi = {10.1002/imo2.70065}
}
Start for free →